Your browser doesn't support javascript.
loading
Visual Aura in Non-Migraine Headaches: A Population Study.
Kim, Seung Jae; Lee, Hye Jeong; Lee, Sue Hyun; Cho, Soomi; Kim, Kyung Min; Chu, Min Kyung.
Affiliation
  • Kim SJ; Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Lee HJ; Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
  • Lee SH; Department of Neurology, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Korea.
  • Cho S; Department of Neurology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.
  • Kim KM; Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Chu MK; Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
J Korean Med Sci ; 38(31): e237, 2023 Aug 07.
Article in En | MEDLINE | ID: mdl-37550805
ABSTRACT

BACKGROUND:

Visual aura (VA) occurs mostly in migraine with aura (MA), but some case studies have reported aura in non-migraine headaches. Thus, information of VA in non-migraine headaches is scarce. Aim of this study was to investigate the prevalence and impact of VA in non-migraine headache and compare it with that of migraine headache.

METHODS:

This study was a nationwide population-based study. We used an internet-based headache diagnosis questionnaire to diagnose headache, and various modules to evaluate clinical features and comorbidities of participants with headache. We defined migraine headache as migraine and probable migraine (PM), whereas non-migraine headache was defined as a headache but not migraine or PM. VA was defined as a self-reporting VA rating scale score ≥ 3.

RESULTS:

Of the 3,030 participants, 1,431 (47.2%) and 507 (16.7%) had non-migraine headache and migraine headache, respectively. VA prevalence was much lower in the non-migraine headache group than in the migraine headache group (14.5% [207/1,431] vs. 26.0% [132/507], P < 0.001). In subjects with non-migraine headache, those with VA had a markedly higher number of headache days per 30 days (median [25th-75th percentiles] 2.0 [1.0-5.0] vs. 2.0 [1.0-3.0], P < 0.001), and headache-related disability (6.0 [3.0-16.0] vs. 2.0 [0.0-7.0], P < 0.001) than those without VA. VA prevalence did not differ significantly according to age and sex.

CONCLUSION:

Non-migraine headache with VA patients had more severe symptoms than those without VA. These findings may improve the understanding of VA and the management of individuals with non-migraine headache.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Migraine with Aura / Epilepsy / Migraine Disorders Type of study: Diagnostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Korean Med Sci Journal subject: MEDICINA Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Migraine with Aura / Epilepsy / Migraine Disorders Type of study: Diagnostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Korean Med Sci Journal subject: MEDICINA Year: 2023 Type: Article